Page 6,392«..1020..6,3916,3926,3936,394..6,4006,410..»

OxyContin Maker Works to Combat Prescription Drug Abuse and Diversion

Posted: Published on October 13th, 2012

The company that manufactures OxyContin is using a variety of ways to combat the abuse and diversion of prescription drugs. Purdue Pharma is monitoring drug counterfeiting and Internet distribution, analyzing pharmacy robberies and thefts, tracking the drug supply chain, and using unique tablet markings, phillyBurbs.com reports. Experts from the company and the FBI came to Pennsylvania this week to train law enforcement officers on preventing and responding to prescription drug abuse and diversion. Our goal is to keep prescription drugs out of the hands of criminals and people who abuse and traffic them and we try to make sure that legitimate patients have access to them, said Landon Gibbs, Director of Law Enforcement Liaison and Education at Purdue. The company uses data from RxPATROL, an information clearinghouse for data related to pharmacy robberies, burglaries and thefts involving controlled substances. The system collects, analyzes and disseminates pharmacy theft information to law enforcement across the country. Purdue also evaluates products seized by law enforcement, to determine if they are genuine or counterfeit. This information helps police find and prosecute drug counterfeiters, and those who divert drugs, the article notes. The company uses special markings, called indicia, to help law enforcement figure out … Continue reading →

Posted in Internet Pharmacy | Comments Off on OxyContin Maker Works to Combat Prescription Drug Abuse and Diversion

How 3D Printers Are Reshaping Medicine

Posted: Published on October 13th, 2012

Printing off a kidney or another human organ may sound like something out of a science fiction novel, but with the advancements in 3D printing technology, the idea may not be so far-fetched. BioprintingWhile 3D printing has been successfully used in the health care sector to make prosthetic limbs, custom hearing aids and dental fixtures, the technology is now being used to create more complex structures - particularly human tissue. Organovo (onvo), a San Diego-based company that focuses on regenerative medicine, is one company using 3D printers, called bioprinters, to print functional human tissue for medical research and regenerative therapies. "This is disruptive technology," said Mike Renard, Organovo's vice president of commercial operations. "It's always interesting and fun, but never easy." (More From CNBC: 15 Surprising Global Technology Cities) Traditional 3D printing, also known as additive manufacturing, is a process of making three dimensional solid objects from a digital model. 3D printing is achieved using additive processes, in which an object is created by laying down successive layers of material such as plastic, ceramics, glass or metal to print an object. Companies including Boeing (ba), General Electric (ge) and Honeywell (hon) use this type of 3D printing to manufacture parts. … Continue reading →

Posted in Cell Medicine | Comments Off on How 3D Printers Are Reshaping Medicine

Leading Researchers to Unite at Texas State Capitol for Regenerative Medicine and Stem Cell Research

Posted: Published on October 13th, 2012

AUSTIN, Texas, Oct. 12th, 2012 /PRNewswire-USNewswire/ -- Prominent stem cell scientists, physicians, and advocates from leading medical facilities and research institutions across Texas and California will highlight the 3rd Annual Stem Cell Research Symposium: Spotlight on Texas, on October 19, 2012, at the Texas State Capitol. This free, public symposium, produced and co-hosted by the Austin-based nonprofit Texas Cures Education Foundation (Texas Cures), is designed to educate the public about the exciting stem cell research andclinical trials currently under way in Texas.The event will also include a discussion of recent Texas laws affecting stem cell research, the potential economic impact of stem cell research and highlight the current progress in one of the most promising areas of medicine. This year, more than a dozen local and national advocacy groups, institutions and foundations showed their support for the efforts of the hosting organizations Texas Cures and Texans for Stem Cell Research including the Genetics Policy Institute, Alliance for Regenerative Medicine and Texans for Advancement of Medical Research. The symposium begins at 8:30 a.m. in the Capitol Extension Auditorium (E1.004), located at the Texas State Capitol Building. Admission is free and open to the public.Registration is recommended. This program unites the diverse … Continue reading →

Posted in Cell Medicine | Comments Off on Leading Researchers to Unite at Texas State Capitol for Regenerative Medicine and Stem Cell Research

Regenevéda Opens Flagship Stem Cell Therapy Clinic in Beverly Hills

Posted: Published on October 13th, 2012

Regenevda recently opened its brand new flagship facility in Beverly Hills, specializing in cutting edge anti-aging treatments such as Stem Cell Therapy. Beverly Hills, CA (PRWEB) October 12, 2012 Dr. Thom Lobe is an internationally respected surgeon and has been in practice for over 30 years. Consistently pioneering advances in medicine, Dr. Lobe was one of the first doctors to ever separate conjoined twins. Consistently working to help make advances in medicine, Dr. Lobe also has over 200 publications to his credit. Overseeing the business aspect of Regenevda is Lindsey Combs. She is responsible for sales, staff, accounting, facility management, and business development. A graduate of the University of California, Los Angeles, Ms. Combs has been working in the anti-aging field for over 10 years and has been a California Licensed Esthetician since 2003. Being one of the very few physicians in the country to hold the most advanced board certification (FAARM), Dr. Lobe is able to offer Stem Cell Therapy at the Regenevda clinic. Inside each persons own body, there are special cells in nearly every organ and tissue that have the ability to help heal damage. These special cells are called Stem Cells and this therapy works by … Continue reading →

Posted in Cell Therapy | Comments Off on Regenevéda Opens Flagship Stem Cell Therapy Clinic in Beverly Hills

Global Autologous Cell Therapy Market worth $2.2 Billion by 2017

Posted: Published on October 13th, 2012

DALLAS, October 12, 2012 /PRNewswire/ -- The report "Autologous Cell Therapy Market(2012 - 2017)", published by MarketsandMarkets (http://www.marketsandmarkets.com), would be the first global and exclusive report on ACT market. It also gives clear information about the complete industry, approved products and potential market size; it also identifies driving and restraining factors for the global ACT market with analysis of trends, opportunities and challenges. The market is segmented and revenue is forecasted on the basis of major regions such as USA, Europe and Rest of the World (ROW). Further, market is segmented and revenues are forecasted on the basis of potential application areas of ACT. Browse ACT market research data tables/figures spread through 111 slides and in-depth TOC on"Autologous Cell Therapy (ACT) Market (2012 - 2017)". http://www.marketsandmarkets.com/Market-Reports/autologous-cell-therapy-market-837.html Early buyers will receive 10% customization on reports. There is a wide market potential and favorable landscape for adoption across many geographical locations of the world. During the forecast period, these technologies are expected to revolutionize the area of bio-pharma and personalized medicine. High incidence and lack of effective treatment for several diseases will drive the ACT technology in developed and developing nations. Investment activities, for past five years are actively held in research … Continue reading →

Posted in Cell Therapy | Comments Off on Global Autologous Cell Therapy Market worth $2.2 Billion by 2017

European Regulators Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Posted: Published on October 13th, 2012

Posted by Michael A. StrattonOctober 12, 2012 7:05 AM Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drugs label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA),the new guidance should include more specific information on when Pradaxa must not be used, as well as advice on managing patients and reversing the anticoagulant effect if Pradaxa bleeding occurs. Pradaxa was approved in Europe in March 2008 for the prevention of venous thromboembolic events following hip or knee replacement surgery. The blood thinner recently had its European approval expanded to cover patients with non-valvular atrial fibrillation to prevent stroke and systemic embolism. According to a report from Pharma Times, the number of fatal bleeding events among Pradaxa users spiked following that expansion. The EMAs Committee for Medicinal Products for Human Use (CHMP) had concluded an earlier review of Pradaxa in November 2011, after it had been linked to 250 patient deaths. At the time, CHMP asked that label information on bleeding risks be strengthened. The Committee also advised caution when using Pradaxa, and said it should be prescribed at lower doses to older patients and … Continue reading →

Posted in Drug Side Effects | Comments Off on European Regulators Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

How social data could help expose drug side effects, personalize prescriptions

Posted: Published on October 13th, 2012

Social data pulled from online health forums and the comments section of blogs is helping patients learn about side effects to various drugs and could ultimately help them figure out the medications that suit them best. As a senior in high school, Julia Winn was diagnosed with clinical depression. For two years, she took medication, sought therapy and saw 10 different doctors, but no one could figure out a cause. Finally, after seeing a specialist, she learned that the culprit was her hormonal birth control pill, which has a well-documented relationship with depression. Using her medical history and experience with the first birth control pill, the specialist recommended a more appropriate alternative and, since then, Winn said shes been fine.But, having figured out the best medication for herself, the 23-year-old Harvard graduate is building a startup that leveragessocial data and natural language processing to help other women discover what could work better for them. The larger goal is to change the way doctors think about patients and change the way patients think about themselves, she told me at the Health 2.0 conference this week in San Francisco. Its not one size fits all. Part of TechStars Bostons fall class, MyBetterFit … Continue reading →

Posted in Drug Side Effects | Comments Off on How social data could help expose drug side effects, personalize prescriptions

NPS Jumps as FDA Staff Backs Risk Plan for Bowel Drug

Posted: Published on October 13th, 2012

NPS Pharmaceuticals Inc. (NPSP) rose the most in about 21 months after a Food and Drug Administration staff report showed the companys lead experimental drug candidate may have a clearer path to U.S. regulatory approval. The drug, Gattex, helps patients with short-bowel syndrome absorb nutrients, weaning them off a time-consuming intravenous nutrition program, the staff said today ahead of an Oct. 16 meeting of FDA advisers who will vote whether to recommend approval. NPS jumped 19 percent to $10.86 at the close in New York, the biggest single-day gain for the Bedminster, New Jersey-based company since Jan. 31, 2011. NPS has advanced 65 percent this year. The FDA staff said it would support NPSs risk-management plan for Gattex, which would be targeted to specialty physicians who understand the dangers associated with the drug, including tumor growth. The staff also suggested additional educational materials for prescribers emphasizing the key serious risks. The FDA is scheduled to make a final decision on Gattex by Dec. 30. The agency does not believe that access to Gattex for SBS should be restricted or require elements to assure safe use, FDA staff wrote, referring to short-bowel syndrome. NPS, which reported about $101 million in revenue … Continue reading →

Posted in Drug Dependency | Comments Off on NPS Jumps as FDA Staff Backs Risk Plan for Bowel Drug

Designer drugs slip past prosecution

Posted: Published on October 13th, 2012

TAMPA The term "designer drug" was coined by a University of California at Davis pharmacologist in the '80s, used to describe man-made drugs more potent than ever. Ecstasy. PCP. GHB. LSD. As legislators outlawed these drugs, manufacturers simply tweaked the formulas to get new, legal versions. Authorities realized they were always behind. So federal lawmakers passed a bill to outlaw designer drugs in 1986. But it has been largely ineffective. Called the Federal Analog Act, the law states that any chemical "substantially similar" to a controlled substance will be treated as one, if intended for human consumption. It was the first time the government had tried to outlaw entire groups of drugs. And it should have stopped bath salts. Over the past century, synthetic drugs have been born in laboratories, usually for medical purposes. Bath salts are primarily derivatives of the drug cathinone. One of the original versions was first distributed as an antidepressant. But people started abusing these drugs. Authorities outlawed cathinone in 1993. See the original post here: Designer drugs slip past prosecution … Continue reading →

Posted in Drugs | Comments Off on Designer drugs slip past prosecution

Drugs, guns, knives going through the post

Posted: Published on October 13th, 2012

Sending drugs and weapons through the post might appeal to some criminals, but they won't necessarily reach their target. In the past 17 months, 75 items have been caught by New Zealand Post and opened as suspicious. Most of those items - including drugs, guns and a knife - were reported to police, detained or destroyed. There were 43 interceptions of cannabis. Ecstasy, cocaine, methamphetamine, ritalin, valium and some unidentified pills and powders were also seized - as was some icing sugar that was mistaken for drugs. Nine weapons were also intercepted. The packages were revealed to The Dominion Post under the Official Information Act. New Zealand Post spokeswoman Jaimee Burke said the postal service was responsible for scanning and identifying mail items transported domestically, and Customs dealt with international mail. "New Zealand Post takes security very seriously and assists Customs and the police in their investigations. Any suspected illegal items found in the post are passed to the police." Seized weapons included two shotguns, a .22-calibre rifle, a knife, two airguns, a replica antique pistol and an antique air rifle. Detective Senior Sergeant Tim Leitch said illegal items found in the mail by New Zealand Post had led to … Continue reading →

Posted in Drugs | Comments Off on Drugs, guns, knives going through the post

Page 6,392«..1020..6,3916,3926,3936,394..6,4006,410..»